| A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data C Xu Computational and structural biotechnology journal 16, 15-24, 2018 | 284 | 2018 |
| Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology IW Deveson, B Gong, K Lai, JS LoCoco, TA Richmond, J Schageman, ... Nature biotechnology 39 (9), 1115-1128, 2021 | 151 | 2021 |
| Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller C Xu, MR Nezami Ranjbar, Z Wu, J DiCarlo, Y Wang BMC genomics 18 (1), 1-11, 2017 | 101 | 2017 |
| smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers C Xu, X Gu, R Padmanabhan, Z Wu, Q Peng, J DiCarlo, Y Wang Bioinformatics 35 (8), 1299-1309, 2019 | 88 | 2019 |
| A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency W Jones, B Gong, N Novoradovskaya, D Li, R Kusko, TA Richmond, ... Genome biology 22 (1), 1-38, 2021 | 30 | 2021 |
| Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions B Gong, D Li, R Kusko, N Novoradovskaya, Y Zhang, S Wang, ... Genome biology 22, 1-23, 2021 | 21 | 2021 |
| Targeted single primer enrichment sequencing with single end duplex-UMI Q Peng, C Xu, D Kim, M Lewis, J DiCarlo, Y Wang Scientific Reports 9 (1), 4810, 2019 | 20 | 2019 |
| Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal … S Lonardi, H Nimeiri, C Xu, DR Zollinger, RW Madison, AD Fine, ... International Journal of Molecular Sciences 23 (19), 11529, 2022 | 15 | 2022 |
| Objective Bayesian analysis for a capture–recapture model C Xu, D Sun, C He Annals of the Institute of Statistical Mathematics 66 (2), 245-278, 2014 | 11 | 2014 |
| Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab M Kansara, N Bhardwaj, S Thavaneswaran, C Xu, JK Lee, LB Chang, ... Molecular Oncology 17 (2), 298-311, 2023 | 8 | 2023 |
| Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling–informed personalized monitoring assay T Powles, A Young, H Nimeiri, RW Madison, A Fine, DR Zollinger, ... Frontiers in Oncology 13, 2023 | 1 | 2023 |
| Predicting primer and panel off-target rate in QIAseq targeted DNA panels using convolutional neural networks C Xu, R Padmanabhan, F Reinecke, J DiCarlo, Y Wang bioRxiv, 2020.07. 13.201558, 2020 | | 2020 |
| Bayesian kernel machine models for testing genetic pathway effects in prostate cancer prognosis C Xu, S Chakraborty Statistical Analysis and Data Mining: The ASA Data Science Journal 10 (6 …, 2017 | | 2017 |
